Maes Pharmconsult SRL
The score of Maes Pharmconsult shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +10 % Total assets +96 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Maes Pharmconsult's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 3,689 € | ||||
| Equity | 160,970 € | ||||
| Cash | 52,413 € | ||||
| EBITDA | 20,624 € | ||||
| Total assets | 471,871 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 04 Mar 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
Maes Pharmconsult's financial analysis
- Solvency34.1%sector median: 49.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Maes Pharmconsult
Maes Pharmconsult's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0875.845.464
- VAT number
- BE0875845464
- Peppol
- Registered · 0208:0875845464 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Aug 2005
- Registered office
- 4600 Visé
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Maes Pharmconsult (SRL) has been based in Visé since 2005, active in: business and other management consultancy activities. For 2025, it reports a net profit of 3,689 € and equity of 160,970 €; its revenue is not published. Its solvency stands at 34.1%, below the median of its sector (49.1%).
Companies similar to Maes Pharmconsult
Companies in the same business, of comparable size and area, outside its group.
- Sygle Business and other management consultancy activities Thuin · balance sheet 471,578 €
- Luca Pullara Management Business and other management consultancy activities Quévy · balance sheet 472,820 €
- EMPIRICAL Consulting Business and other management consultancy activities Quévy · balance sheet 470,621 €
- Apdw Management Business and other management consultancy activities Visé · balance sheet 473,397 €
- Viccel Business and other management consultancy activities Damme · balance sheet 473,432 €
- GDD Management Business and other management consultancy activities Wemmel · balance sheet 473,459 €
- TSI consultancy Business and other management consultancy activities Sint-Niklaas · balance sheet 470,140 €
- Doutry Brecht Business and other management consultancy activities Roeselare · balance sheet 469,920 €
Frequently asked questions about Maes Pharmconsult
What is the revenue of Maes Pharmconsult?
Maes Pharmconsult files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Maes Pharmconsult?
In Belgium, the VAT number is the company number prefixed with BE: BE0875845464 for Maes Pharmconsult, if the company is VAT-registered. Its company number (CBE) is 0875.845.464.
Where is the registered office of Maes Pharmconsult?
According to the CBE register, the registered office of Maes Pharmconsult is in 4600 Visé.
What is the equity of Maes Pharmconsult?
At the close of the 2025 financial year, the equity of Maes Pharmconsult amounts to 160,970 €, a solvency of 34.1% of total assets.
Who manages Maes Pharmconsult?
The register lists 1 active mandates at Maes Pharmconsult. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Maes Pharmconsult
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →